SurGal Clinic s.r.o.

At SurGal Clinic s.r.o. in Brno-Sever, most trials focus on digestive system diseases, especially Crohn’s disease and ulcerative colitis. The studies are aimed at testing new treatments, improving symptom control, and measuring how well therapies support healing and long-term disease management.

• Moderately to severely active Crohn’s disease
• Ulcerative colitis and related inflammatory bowel disease
• Evaluation of targeted therapies for clinical and endoscopic response

This research reflects a strong focus on inflammatory bowel disease care, with efforts to assess both effectiveness and safety of emerging medicines.

The site also contributes to trials in immune system diseases, where researchers are studying how newer therapies can better control chronic inflammation. These studies aim to improve treatment response, maintain remission, and support longer-term tolerability for people living with immune-mediated conditions.

• Moderately to severely active Crohn’s disease and ulcerative colitis
• Assessment of maintenance therapy and sustained disease control
• Safety and efficacy evaluation of novel immune-targeted treatments

Across these trials, the emphasis is on finding more precise ways to manage inflammation while balancing benefit and safety.

Beyond bowel disease, SurGal Clinic s.r.o. is involved in studies of erosive esophagitis due to gastroesophageal reflux disease. The purpose of these trials is to evaluate treatments that may improve healing of the esophagus and help prevent symptoms from returning.

• Erosive esophagitis linked to GERD
• Testing treatment effectiveness for healing and maintenance
• Comparing options to support durable symptom relief

These studies add a broader gastroenterology dimension to the site’s research portfolio.

Some trials explore the overlap between obesity or overweight and inflammatory bowel disease, particularly in patients with ulcerative colitis or Crohn’s disease. The goal is to assess whether combined treatment approaches can address both disease control and weight-related health concerns.

• Ulcerative colitis with obesity or overweight
• Crohn’s disease with obesity or overweight
• Evaluating therapies that may improve remission and weight outcomes together

This area shows interest in more comprehensive care strategies for patients with multiple health needs.

Several studies at the clinic focus on keeping patients well after initial improvement, especially in ulcerative colitis and Crohn’s disease. These trials are designed to understand long-term safety, tolerability, and continued effectiveness of newer therapies used in maintenance care.

• Maintenance treatment in ulcerative colitis
• Long-term support for Crohn’s disease control
• Monitoring ongoing safety and tolerability of emerging therapies

This work helps clarify how investigational treatments may perform over time in routine clinical use.